Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Spotlights Endeavor Stent Launch Abroad, ICDs Domestically

This article was originally published in The Gray Sheet

Executive Summary

Medtronic believes it can capture more than 15% of the international drug-eluting stent market within one year of rolling out its Endeavor in 40 countries outside the U.S
Advertisement

Related Content

Medtronic Presents Durable Endeavor DES Results At ESC Meeting
Boston Scientific Holds To Year-Long Guidance Despite Weak Sales In August
Medtronic Presents Durable Endeavor DES Results At ESC Meeting
Boston Scientific Holds To Year-Long Guidance Despite Weak Sales In August
Medtronic Endeavors To Gain Drug-Eluting Stent Share In Europe
Medtronic Endeavors To Gain Drug-Eluting Stent Share In Europe
Medtronic Launches Obesity Division With $260 Mil. Transneuronix Purchase
Medtronic Touts Endeavor Safety Results; Are Late Lumen Loss Issues Over?
Advertisement
UsernamePublicRestriction

Register

MT022584

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel